Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation
Europace · 19.05.2023 · 25 (5)
DOI: 10.1093/europace/euad129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, online erschienen am 19.05.2023. Verfasst von Satyam Krishan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Oklahoma Health Sciences Center, 800 Stanton L. Young Blvd, AAT 5400, Oklahoma City, OK, 73104, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
Haematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for several malignant and non-malignant haematologic conditions. Patients undergoing HSCT are at an increased risk of developing atrial fibrillation (AF). We hypothesized that a diagnosis of AF would be associated with poor outcomes in patients undergoing HSCT. Methods and results The National Inpatient Sample (2016–19) was queried with ICD-10 codes to identify patients aged >50 years undergoing HSCT. Clinical outcomes were compared between patients with and without AF. A multivariable regression model adjusting for demographics and comorbidities was used to calculate the adjusted odds ratio (aOR) and regression coefficients with corresponding 95% confidence intervals and P-values. A total of 50 570 weighted hospitalizations for HSCT were identified, out of which 5820 (11.5%) had AF. Atrial fibrillation was found to be independently associated with higher inpatient mortality (aOR 2.75; 1.9–3.98; P < 0.001), cardiac arrest (aOR 2.86; 1.55–5.26; P = 0.001), acute kidney injury (aOR 1.89; 1.6–2.23; P < 0.001), acute heart failure exacerbation (aOR 5.01; 3.54–7.1; P < 0.001), cardiogenic shock (aOR 7.73; 3.17–18.8; P < 0.001), and acute respiratory failure (aOR 3.24; 2.56–4.1; P < 0.001) as well as higher mean length of stay (LOS) (+2.67; 1.79–3.55; P < 0.001) and cost of care (+67 529; 36 630–98 427; P < 0.001).
Conclusion
Among patients undergoing HSCT, AF was independently associated with poor in-hospital outcomes, higher LOS, and cost of care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Oklahoma Health Sciences Center, 800 Stanton L. Young Blvd, AAT 5400, Oklahoma City, OK, 73104, USA.
- Department of Cardiovascular Medicine, Electrophysiology Section, University of California Davis, Davis, CA, USA.
- Department of Medicine, West Virginia University, Morgantown, WV, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
- Cardio Oncology Program, MedStar Heart and Vascular Institute, Georgetown University, Washington, DC, USA.
ORCID-Profile: Satyam Krishan, Muhammad Bilal Munir, Muhammad Zia Khan, Ryan Nipp, Abhishek Deshmukh, Stavros Stavrakis, Ana Barac, Zain Ul Abideen Asad
Zitieren
APA
Krishan, S., Munir, M. B., Khan, M. Z., Al-Juhaishi, T., Nipp, R., DeSimone, C. V., Deshmukh, A., Stavrakis, S., Barac, A., & Asad, Z. U. A. (2023). Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation. Europace, 25(5). https://doi.org/10.1093/europace/euad129
Vancouver
Krishan S, Munir MB, Khan MZ, Al-Juhaishi T, Nipp R, DeSimone CV, et al. Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation. Europace. 2023;25(5). doi:10.1093/europace/euad129
BibTeX
@article{Krishan2023,
author = {Krishan, Satyam and Munir, Muhammad Bilal and Khan, Muhammad Zia and Al-Juhaishi, Taha and Nipp, Ryan and DeSimone, Christopher V and Deshmukh, Abhishek and Stavrakis, Stavros and Barac, Ana and Asad, Zain Ul Abideen},
title = {Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation},
journal = {Europace},
year = {2023},
volume = {25},
number = {5},
doi = {10.1093/europace/euad129}
}
EUVIMED